Y Saïdi

1.3k total citations
9 papers, 188 citations indexed

About

Y Saïdi is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Y Saïdi has authored 9 papers receiving a total of 188 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 3 papers in Virology and 2 papers in Epidemiology. Recurrent topics in Y Saïdi's work include HIV Research and Treatment (3 papers), HIV/AIDS Research and Interventions (3 papers) and HIV/AIDS drug development and treatment (3 papers). Y Saïdi is often cited by papers focused on HIV Research and Treatment (3 papers), HIV/AIDS Research and Interventions (3 papers) and HIV/AIDS drug development and treatment (3 papers). Y Saïdi collaborates with scholars based in France, United Kingdom and United States. Y Saïdi's co-authors include A.‐J. Valleron, Stanislas Pol, Ophélie Godon, Sandrine Kahi, Daniel Scott‐Algara, Hélène Fontaine, Anne Varaut, J.-P. Aboulker, Marie‐Louise Michel and Cyrille Chazallon and has published in prestigious journals such as The Lancet, Gut and Annals of the New York Academy of Sciences.

In The Last Decade

Y Saïdi

9 papers receiving 184 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Y Saïdi France 6 116 99 66 41 20 9 188
R Piscopo Italy 5 187 1.6× 133 1.3× 147 2.2× 78 1.9× 8 0.4× 10 287
Simnikiwe H. Mayaphi South Africa 9 148 1.3× 93 0.9× 95 1.4× 52 1.3× 5 0.3× 17 204
Alessandro Chiodera Italy 9 108 0.9× 135 1.4× 86 1.3× 91 2.2× 24 1.2× 14 260
Matthieu Godinot France 5 120 1.0× 66 0.7× 78 1.2× 36 0.9× 8 0.4× 10 159
Berend J. van Welzen Netherlands 9 78 0.7× 136 1.4× 58 0.9× 98 2.4× 12 0.6× 26 216
Robert Zangerle Austria 6 58 0.5× 82 0.8× 11 0.2× 86 2.1× 17 0.8× 15 153
Nokukhanya Msomi South Africa 5 43 0.4× 99 1.0× 23 0.3× 15 0.4× 5 0.3× 17 131
Jesús Repáraz Spain 7 98 0.8× 100 1.0× 24 0.4× 13 0.3× 6 0.3× 18 159
Laurent Hustache‐Mathieu France 7 64 0.6× 66 0.7× 56 0.8× 16 0.4× 6 0.3× 19 131
Yi‐Chia Huang Taiwan 11 178 1.5× 164 1.7× 161 2.4× 77 1.9× 6 0.3× 20 301

Countries citing papers authored by Y Saïdi

Since Specialization
Citations

This map shows the geographic impact of Y Saïdi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y Saïdi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y Saïdi more than expected).

Fields of papers citing papers by Y Saïdi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y Saïdi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y Saïdi. The network helps show where Y Saïdi may publish in the future.

Co-authorship network of co-authors of Y Saïdi

This figure shows the co-authorship network connecting the top 25 collaborators of Y Saïdi. A scholar is included among the top collaborators of Y Saïdi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y Saïdi. Y Saïdi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Happel, Anna‐Ursula, Nonhlanhla Yende‐Zuma, Y Saïdi, et al.. (2025). Randomized trial of multi-strain Lactobacillus crispatus vaginal live biotherapeutic products after antibiotic therapy for bacterial vaginosis: study protocol for VIBRANT (vaginal lIve biotherapeutic RANdomized trial). Contemporary Clinical Trials Communications. 48. 101554–101554. 1 indexed citations
2.
Maqbul, Muazzam Sheriff, et al.. (2024). A Study on the Self-Reported Physician-Diagnosed Cardiac Complications Post mRNA Vaccination in Saudi Arabia. Cureus. 16(1). e52108–e52108. 1 indexed citations
3.
Freguja, Riccardo, Alasdair Bamford, Marisa Zanchetta, et al.. (2020). Long‐term clinical, virological and immunological outcomes following planned treatment interruption in HIV‐infected children. HIV Medicine. 22(3). 172–184. 2 indexed citations
4.
Fontaine, Hélène, Sandrine Kahi, Cyrille Chazallon, et al.. (2014). Anti-HBV DNA vaccination does not prevent relapse after discontinuation of analogues in the treatment of chronic hepatitis B: a randomised trial—ANRS HB02 VAC-ADN. Gut. 64(1). 139–147. 78 indexed citations
5.
Gibb, Diana M., Marc Lallemant, Y Saïdi, et al.. (2008). O222 Treatment interruption in children with chronic HIV-infection: the results of the paediatric European network for treatment of AIDS (PENTA) 11 trial. Journal of the International AIDS Society. 11(Suppl 1). O21–O21. 7 indexed citations
6.
Gibb, Diana M., Deenan Pillay, Karina Butler, et al.. (2007). Lamivudine/abacavir maintains virological superiority over zidovudine/lamivudine and zidovudine/abacavir beyond 5 years in children. AIDS. 21(8). 947–955. 48 indexed citations
7.
Carrière, Isabelle, JH Darbyshire, Carlo Giaquinto, et al.. (1998). A randomized double-blind trial of the addition of lamivudine or matching placebo to current nucleoside analogue reverse transcriptase inhibitor therapy in HIV-infected children: The PENTA-4 trial. UCL Discovery (University College London). 12(14). 13 indexed citations
8.
Flahault, Antoine, et al.. (1995). Sentinelle traces of an epidemic of acute gastroenteritis in France. The Lancet. 346(8968). 162–163. 16 indexed citations
9.
Saïdi, Y, et al.. (1992). The French Communicable Diseases Computer Network. Annals of the New York Academy of Sciences. 670(1). 29–42. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R Piscopo Breakdown of academic impact, for papers by Simnikiwe H. Mayaphi Breakdown of academic impact, for papers by Alessandro Chiodera Breakdown of academic impact, for papers by Matthieu Godinot Breakdown of academic impact, for papers by Berend J. van Welzen Breakdown of academic impact, for papers by Robert Zangerle Breakdown of academic impact, for papers by Nokukhanya Msomi Breakdown of academic impact, for papers by Jesús Repáraz Breakdown of academic impact, for papers by Laurent Hustache‐Mathieu Breakdown of academic impact, for papers by Yi‐Chia Huang
Rankless by CCL
2026